当前位置: 首页 > 详情页

Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Childrens Hosp, Beijing 100045, Peoples R China; [2]Shanghai Childrens Hosp, Shanghai 200040, Peoples R China; [3]Guangzhou Childrens Hosp, Guangzhou, Peoples R China; [4]Capital Med Univ, Beijing Childrens Hosp, 56 Nan Lishi Rd, Beijing 100045, Peoples R China
出处:
ISSN:

关键词: Haemophilus influenzae antimicrobial susceptibility ampicillin resistance beta-lactamase China paediatrics

摘要:
This prospective, three-centre study tested for antimicrobial susceptibility in 898 isolates of Haemophilus influenzae between 2000 and 2002 in Chinese children aged under 5 years with acute upper respiratory tract infection. The average incidence of P-lactamase production was 12.0%. Overall, 88.0% of isolates were susceptible to ampicillin, 100.0% were susceptible to arnoxicillin/clavulanic acid, ceftriaxone, cefuroxime and azithromycin, and 99.0% were susceptible to ciprofloxacin. Isolates from Beijing and Shanghai had a lower susceptibility to tetracycline (57.0% and 61.0%, respectively) compared with those from Guangzhou (81.0%), while trimethoprim/sulfamethoxazole susceptibilities in Shanghai (47.0%) and Guangzhou (54.0%) were significantly higher than in Beijing (35.0%). A total of 34.5% of all the isolates were susceptible to all eight of these antimicrobial agents and 12.8% were multi-drug resistant. Ampicillin resistance increased over the duration of the study. These findings show that P-lactamase production and ampicillin resistance among isolates from Chinese children with upper respiratory tract infection are increasing, and highlight the strong correlation between ampicillin resistance and resistance to cefaclor, chloramphenicol and tetracycline in H. influenzae isolates.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2006]版:
大类 | 4 区 医学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2005]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2005版] 出版当年五年平均 出版前一年[2004版] 出版后一年[2006版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Childrens Hosp, Beijing 100045, Peoples R China; [2]Shanghai Childrens Hosp, Shanghai 200040, Peoples R China; [3]Guangzhou Childrens Hosp, Guangzhou, Peoples R China; [4]Capital Med Univ, Beijing Childrens Hosp, 56 Nan Lishi Rd, Beijing 100045, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Childrens Hosp, Beijing 100045, Peoples R China; [2]Shanghai Childrens Hosp, Shanghai 200040, Peoples R China; [3]Guangzhou Childrens Hosp, Guangzhou, Peoples R China; [4]Capital Med Univ, Beijing Childrens Hosp, 56 Nan Lishi Rd, Beijing 100045, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院